K. Piras-Straub

Glutamate Dehydrogenase and Alkaline Phosphatase as Very Early Predictors of Hepatocellular Carcinoma Recurrence after Liver Transplantation

G. Gerken, A. Canbay, A. Paul, 2015, Digestion.

A ‐1573T>C SNP within the human TRAIL promoter determines TRAIL expression and HCC tumor progression

G. Gerken, A. Paul, K. Herzer, 2016, Cancer medicine.

TRAIL expression levels in human hepatocellular carcinoma have implications for tumor growth, recurrence and survival

G. Gerken, A. Canbay, H. Baba, 2015, International journal of cancer.

The influence of immunosuppressants on direct‐acting antiviral therapy is dependent on the hepatitis C virus genotype

G. Gerken, A. Walker, K. Herzer, 2018, Transplant infectious disease : an official journal of the Transplantation Society.

Effects of the Mammalian Target of Rapamycin Inhibitor Everolimus on Hepatitis C Virus Replication In Vitro and In Vivo.

G. Gerken, T. Hofmann, A. Walker, 2017, Transplantation proceedings.

Management of telaprevir-based triple therapy for hepatitis C virus recurrence post liver transplant.

G. Gerken, A. Canbay, A. Paul, 2015, World journal of hepatology.